Author:
Elsayed Ahmad,Humaidan Mohammed Fahad AL,Hawsawi Anhar Othman,Muammar Mohammed Fahad Bin,AlZahrani Abdulhadi Abdurahman,Albarrak Basil Ahmed,AlJarrash Yasmin Radi,ALZahrani Saeed Mohammed,AlZahrani Omar Mohammed,AlYateem Sara Nabil,AlAzmi Majed Abdullah
Reference19 articles.
1. Cardiovascular Working Group. (2017). Treatment of deep vein thrombosis and pulmonary embolism. Melbourne: Therapeutic Guidelines Limited.
2. EINSTEIN–PE Investigators, Büller, H. R., Prins, M. H., Lensin, A. W., Decousus, H., Jacobson, B. F., Minar, E., Chlumsky, J., Verhamme, P., Wells, P., et al. (2012). Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. The New England Journal of Medicine, 366(14), 1287-1297.
3. Ghaffar, F. A., Redzuan, A. M., & Makmor-Bakry, M. (2021). Effectiveness of Sildenafil in Pulmonary Hypertension Secondary to Valvular Heart Disease: A Systematic Review and Meta-Analysis. Archives of Pharmacy Practice, 12(3), 55-65.
4. Gholizadeh, B., Zadeh, F. J., Nabavi, S. S., Moradi-Joo, E., & Baghaei, S. (2021). The Relationship between Quality of Life and Mental Health in Patients with Heart Failure. Journal: Entomology and Applied Science Letters, (3), 60-66.
5. Goergen, S., Tran, H., Jong, I., & Zallman, M. (2015). Suspected pulmonary embolism. Sydney: The Royal Australian and New Zealand College of Radiologists.